Stocktoria
DarioHealth Corp. DRIO
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-03-08
DarioHealth Corp. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 56.6% | 49.1% | 29.4% | 34.9% | 19.3% |
| Operating margin | -163.9% | -213.6% | -276.1% | -205.4% | -372.9% |
| Net margin | -186.6% | -158.1% | -292.0% | -224.9% | -374.2% |
| FCF margin | -116.7% | -143.1% | -152.1% | -174.6% | -247.0% |
| Return on assets | -37.9% | -36.0% | -61.7% | -52.2% | -76.2% |
| Return on equity | -61.4% | -59.4% | -102.2% | -77.7% | -89.7% |
| Debt / equity | 0.45× | 0.33× | 0.42× | 0.23× | 0.00× |
| Current ratio | 3.76 | 2.44 | 3.79 | 3.39 | 3.17 |
| Revenue growth | -17.3% | 32.9% | -26.4% | 34.8% | 170.8% |
Source: SEC EDGAR filings · CIK 0001533998 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.